The company expects its 2025 adjusted earnings to be in the range of $2.80 to $2.87 per share, above analysts' average ...

Dozens of patients of the Norfolk and Norwich University Hospital have been warned they are at "high risk" due to faulty pacemakers.

Boston Scientific Corporation ( NYSE: BSX) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ET Jonathan Monson - SVP, IR Michael Mahoney - Chairman and CEO Daniel Brennan - EVP and CFO ...

Q4 2024 Earnings Call Transcript February 5, 2025 Operator: Good morning, and welcome to the Boston Scientific Fourth Quarter 2024 Earnings Call. [Operator Instructions] Please note this event is ...

Advancements and Projections in the Global Cardiac Rhythm Management Devices Market: Insights, Trends, Opportunities, and ...

Learn more about whether Boston Scientific Corporation or Penumbra, Inc. is a better investment based on AAII's A+ Investor ...

A pair of artificial intelligence algorithms from Boston Scientific and Medtronic can ... worsening heart failure in people with CIEDs – pacemakers, implantable cardioverter defibrillators ...

The catheters shown here are for (from top to bottom) Boston Scientific’s Farapulse ... The Micra AV2 and Micra VR2 leadless pacemakers. [Images courtesy of Medtronic] Medtronic won CE mark ...

Compared with key medical device competitors, including Boston Scientific, Medtronic ... costs once implanted inside the body, including pacemakers, implantable cardioverter defibrillators ...

Abbott Laboratories ABT is set to report fourth-quarter fiscal 2024 results on Jan. 22. See the Zacks Earnings Calendar to stay ahead of market-making news. For fourth-quarter fiscal 2024, Abbott ...